Cardiac Wire #303 September 11, 2025
ASE 2025 Highlights, VEST for PAH, and BSCI’s Bioenvelope Purchase
Cardiac Wire #302 September 8, 2025
Edwards Acquires Vectorious, FFR Revascularization, and AFib Monitoring
Cardiac Wire #301 September 4, 2025
ODYSSEY vs. MAPLE, ESC Studies, and Kardium’s FDA Approval
Cardiac Wire #300 August 28, 2025
Cardiology Lifestyle Troubles, AI for Heart Block, and DAPT Differences
Cardiac Wire #299 August 25, 2025
Real-World GLP Costs, Rocket Off Hold, and TAVR Deterioration
Cardiac Wire #298 August 21, 2025
CSP Helps AV Block, Generic Entresto, and Self-Plagiarism
Cardiac Wire #297 August 18, 2025
Rivaroxaban for AFib + CAD, HF is Preventable, and PFA’s Phrenic Impact
Cardiac Wire #296 August 14, 2025
TEER for AFMR, Recalls Galore, and Plane Noise BP
Cardiac Wire #295 August 11, 2025
TAVR in 2025, FTC vs. Edwards, and Pregablin HF Link
Cardiac Wire #294 August 7, 2025
Lilly Outdoes Itself, Leqvio Monotherapy, and OMRON’s HF Detection
Cardiac Wire #293 August 4, 2025
Pre/Post-CVD Activity, COVID vs. Flu Impact, and Aging Arteries
Cardiac Wire #292 July 31, 2025
AZ’s Anselamimab Hurdle, GDMT for HF, and Roche Cuts CT-173
Cardiac Wire #291 July 28, 2025
SGLT2i Uptake Disparities, The DECIDE Registry, and Unethical Organ Harvesting
Cardiac Wire #290 July 24, 2025
SCCT25’s Top Trends, MI Mix-Ups, and EchoNext
Cardiac Wire #289 July 21, 2025
Polypills’ CVD Potential, Renal Denervation Coverage, and Hypertension in Women
Cardiac Wire #288 July 17, 2025
Kerendia for HF, PREVENT underperforms, and Women’s Hypertension
Cardiac Wire #287 July 14, 2025
CV Deaths Change, SAVR stagnation, and Elderly ACS
Cardiac Wire #286 July 10, 2025
H1 Top 6 Cardiology Trends and More
Cardiac Wire #285 July 3, 2025
